Combined therapy with cytosine arabinoside (NSC-63878) and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962) for advanced solid tumors.
D000328:Adult; D000477:Alkylating Agents / Q000627:therapeutic use*; D001772:Blood Cell Count; D002330:Carmustine / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D009603:Nitroso Compounds / Q000627:therapeutic use*; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D013997:Time Factors; D014508:Urea / Q000627:therapeutic use*
D000477:Alkylating Agents; D004338:Drug Combinations; D009603:Nitroso Compounds; D009607:Nitrosourea Compounds; D003561:Cytarabine; D014508:Urea; D002330:Carmustine